European Journal of Preventive Cardiology

Article	Citations
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of th	355
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study	338
Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017	253
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19)	223
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice	202
The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiolo	120
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European A	105
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases	93
Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the Euro	86
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic	82
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular	71
HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies	71
Effectiveness of home-based cardiac telerehabilitation as an alternative to Phase 2 cardiac rehabilitation of coronary heart disease: a systematic review and meta-analysis	71
Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on H	70
Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: A nationwide population-based cohort study	66
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–2019	65
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead	64
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction	63
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation	57
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings	56
Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis	54
Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the	51
Role of gender, age and BMI in prognosis of heart failure	47
Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies	46
Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis	45

Sport and exercise during and beyond the COVID-19 pandemic	45
Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic	42
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working	40
Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys	40
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing	40
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions	39
Physical exercise training in patients with a Fontan circulation: A systematic review	38
Future-proofing cardiac rehabilitation: Transitioning services to telehealth during COVID-19	37
Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990−2019: findings from 2019 global burden of disease study	37
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis	37
Obesity, overweight and risk for cardiovascular disease and mortality in young women	37
Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations	36
Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project	36
Effects of exercise rehabilitation in patients with long coronavirus disease 2019	36
Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation	36
Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management	32
Yield and clinical significance of genetic screening in elite and amateur athletes	32
Long-term cumulative blood pressure in young adults and incident heart failure, coronary heart disease, stroke, and cardiovascular disease: The CARDIA study	32
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017	32
Non-genetic risk factors for atrial fibrillation are equally important in both young and old age: A nationwide population-based study	32
Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis	31
Abdominal aortic calcification: from ancient friend to modern foe	31
Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis	30
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid	30
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system	30
C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism	30
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines	30
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial	30
Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort study	29
Myocarditis in athletes: A clinical perspective	29
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy	29
The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review	29
Combined use of trimethylamine N-oxide with BNP for risk stratification in heart failure with preserved ejection fraction: findings from the DIAMONDHFpEF study	29
Coffee consumption and mortality from cardiovascular diseases and total mortality: Does the brewing method matter?	29
Participation in exercise-based cardiac rehabilitation is related to reduced total mortality in both men and women: results from the SWEDEHEART registry	28
Finding very high lipoprotein(a): the need for routine assessment	28
Self-reported daytime napping, daytime sleepiness, and other sleep phenotypes in the development of cardiometabolic diseases: a Mendelian randomization study	27
Physical activity/inactivity and COVID-19	27
Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study	27
Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European	27
Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin	26
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive	26
EAPC Core Curriculum for Preventive Cardiology	26
Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy	26
Life’s Essential 8 and the risk of cardiovascular disease death and all-cause mortality in Finnish men	26
Global magnitude and temporal trend of infective endocarditis, 1990–2019: results from the Global Burden of Disease Study	26
Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective	26
Vascular ageing: moving from bench towards bedside	26
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry	25
Triglyceride–glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study	25

Cardiovascular disease and COVID-19: les liaisons dangereuses	25
Home blood pressure during COVID-19-related lockdown in patients with hypertension	25
Improvements in exercise capacity of older adults during cardiac rehabilitation	24
Association between insulin resistance and risk of atrial fibrillation in non-diabetics	24
Multimodal prehabilitation as a promising strategy for preventing physical deconditioning on the heart transplant waiting list	24
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry	24
Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC)	23
The use of cardiac imaging in the evaluation of athletes in the clinical practice: A survey by the Sports Cardiology and Exercise Section of the European Association of Preventive Cardiology and Unive	23
Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy	23
Gut microbiome and risk of ischaemic stroke: a comprehensive Mendelian randomization study	23
Dose–response effects of physical activity on all-cause mortality and major cardiorenal outcomes in chronic kidney disease	22
Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017	22
Prognostic role of transferrin saturation in heart failure patients	22
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with t	22
Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease	22
The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank	22
The effects of transitions in metabolic health and obesity status on incident cardiovascular disease: Insights from a general Chinese population	22
Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990–2019	22
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterizatio	22
Short-term effects of particulate matter on cardiovascular morbidity in Italy: a national analysis	22
Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patien	22
Association between change in cardiorespiratory fitness and incident hypertension in Swedish adults	21
Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study	21
Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study	21
Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model	21
Cardiac rehabilitation and all-cause mortality in patients with heart failure: a retrospective cohort study	21
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study	21
Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC)	21
Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-19	20
How spaceflight challenges human cardiovascular health	20
Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia	20
Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era	20
Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: A systematic review and meta-analysis of randomized controlled trials	20
Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population	20
The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank	20
Combined aerobic/resistance/inspiratory muscle training as the ‘optimum’ exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial	20
Light to moderate coffee consumption is associated with lower risk of death: a UK Biobank study	20
Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis	20
Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure	19
Cardiorespiratory fitness and survival following cancer diagnosis	19
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors	19
Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction	19
Amiodarone as a possible therapy for coronavirus infection	19
Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029	19
Novel antidiabetic drugs and risk of cardiovascular events in patients without baseline metformin use: a meta-analysis	19
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction	19
Setting your clock: associations between timing of objective physical activity and cardiovascular disease risk in the general population	19
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease	19
Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry	19
Biventricular mechanical pattern of the athlete’s heart: comprehensive characterization using three-dimensional echocardiography	19
The DASH diet is associated with a lower risk of heart failure: a cohort study	19
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study	18
Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study	18
Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias.	18
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies	18
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis	18
Cardiovascular risk stratification by coronary computed tomography angiography imaging: current state-of-the-art	18
Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study	18
Menopause modulates the circulating metabolome: evidence from a prospective cohort study	18
Effect of coronavirus infection on the human heart: A scoping review	18
Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality	17
Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study	17
Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry	17
Association between estimated pulse wave velocity and the risk of cardiovascular outcomes in men	17
Acute effect of heat-not-burn versus standard cigarette smoking on arterial stiffness and wave reflections in young smokers	17
Sex differences on new-onset heart failure in patients with known or suspected coronary artery disease	17
Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors	17
Next-generation sequencing to confirm clinical familial hypercholesterolemia	17
Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis	17
The relationship between blood pressure and risk of atrial fibrillation: a Mendelian randomization study	17
Risk stratification in cardiomyopathy	16
Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism	16
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study	16
Non-adherence to established dietary guidelines associated with increased mortality: the Copenhagen General Population Study	16
Anticoagulation for atrial fibrillation in active cancer: what the cardiologists think	16
Associations of genetic susceptibility and healthy lifestyle with incidence of coronary heart disease and stroke in individuals with hypertension	16
‘Life’s Essential 8’ cardiovascular health with premature cardiovascular disease and all-cause mortality in young adults: the Kailuan prospective cohort study	16
Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry	16
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrants	16
Functional capacity assessment and Minimal Clinically Important Difference in post-acute cardiac patients: the role of Short Physical Performance Battery	16

Sex differences in optimal medical therapy following myocardial infarction according to left ventricular ejection fraction	16
Taking the next steps to implement polygenic risk scoring for improved risk stratification and primary prevention of coronary artery disease	15
Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention	15
Normative cardiopulmonary exercise data for endurance athletes: the Cardiopulmonary Health and Endurance Exercise Registry (CHEER)	15
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction	15
Time trends in ischaemic heart disease incidence and mortality over three decades (1990–2019) in 20 Western European countries: systematic analysis of the Global Burden of Disease Study 2019	15
Diagnostic and prognostic value of low QRS voltages in cardiomyopathies: old but gold	15
High visit-to-visit cholesterol variability predicts heart failure and adverse cardiovascular events: a population-based cohort study	15
Association of pre-pregnancy cardiovascular risk factor burden with adverse maternal and offspring outcomes	15
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy	15
Less revascularization in young women but impaired long-term outcomes in young men after myocardial infarction	15
How do General Practitioners assess physical activity and prescribe exercise in patients with different cardiovascular diseases? An Italian pilot study	15
Global burden of rheumatic heart disease and its association with socioeconomic development status, 1990–2019	15
Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterization	15
Incidence and prognosis of COVID-19 amongst heart transplant recipients: a systematic review and meta-analysis	15
Athletes with valvular heart disease and competitive sports: a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology	14
Sex steroids and markers of micro- and macrovascular damage among women and men from the general population	14
ECG criteria for the detection of high-risk cardiovascular conditions in master athletes	14
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP	14
Trends in blood pressure, blood lipids, and smoking from 259 753 patients with hypertension in a Swedish primary care register: results from QregPV	14
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials	14
Impact of environmental pollution and weather changes on the incidence of ST-elevation myocardial infarction	14
Exercise intolerance and fatigue in chronic heart failure: is there a role for group III/IV afferent feedback?	14
Clinical correlates and outcome of the patterns of premature ventricular beats in Olympic athletes: a long-term follow-up study	13
Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study	13
Age-dependent associations of body mass index with myocardial infarction, heart failure, and mortality in over 9 million Koreans	13
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	13
Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed?	13
Obesity, cardiovascular risk and healthcare resource utilization in the UK	13
Cardiovascular event rates increase after each recurrence and associate with poor statin adherence	13
The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk	13
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study	13
Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis	13
The role of cardiopulmonary exercise testing in predicting mortality and morbidity in people with congenital heart disease: a systematic review and meta-analysis	13
miR-181c level predicts response to exercise training in patients with heart failure and preserved ejection fraction: an analysis of the OptimEx-Clin trial	13
Influence of visceral adiposity accumulation on adverse left and right ventricular mechanics in the community	13
High-density lipoprotein cholesterol and cardiovascular mortality: a prospective cohort study among 15.8 million adults	13
The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulatio	13
Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology—Cardiovascular Round Table	13
Comparison of MAGGIC and MECKI risk scores to predict mortality after cardiac rehabilitation among Dutch heart failure patients	13
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017–2020	12
Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study	12
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities	12
Remnant cholesterol, low-density lipoprotein cholesterol, and incident cardiovascular disease among Koreans: a national population-based study	12
Prevalence and extent of coronary artery calcification in the middle-aged and elderly population	12
Success factors in high-effect, low-cost eHealth programs for patients with hypertension: a systematic review and meta-analysis	12
Epigenetics in the primary and secondary prevention of cardiovascular disease: influence of exercise and nutrition	12
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes	12
Temporal trends and predictors of inhospital death in patients hospitalised for heart failure in Germany	12
Iron deficiency in heart failure—time to redefine	12
Prescribing, dosing and titrating exercise in patients with hypertrophic cardiomyopathy for prevention of comorbidities: Ready for prime time	12
Dipping pattern and short-term blood pressure variability are stronger predictors of cardiovascular events than average 24-h blood pressure in young hypertensive subjects	12
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: A systematic review and meta-analysis	12
Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis	11
Extracellular vesicle species differentially affect endothelial cell functions and differentially respond to exercise training in patients with chronic coronary syndromes	11
Saturated fat: villain and bogeyman in the development of cardiovascular disease?	11
Workload-indexed blood pressure response to a maximum exercise test among professional indoor athletes	11
Remnant cholesterol in patients admitted for acute coronary syndromes	11
Joint association of physical activity and sleep duration with risk of all-cause and cause-specific mortality: a population-based cohort study using accelerometry	11
A resilient type of familial hypercholesterolaemia: case–control follow-up of genetically characterized older patients in the SAFEHEART cohort	11
Aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis	11
Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis	11
Parental cardiovascular health predicts time to onset of cardiovascular disease in offspring	11
Cardiac magnetic resonance in patients with muscular dystrophies	11
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome	11
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology	11
Vegetarianism, microbiota, and cardiovascular health: looking back, and forward	11
Management of complications of cardiac amyloidosis: 10 questions and answers	11
Physical activity attenuates cardiovascular risk and mortality in men and women with and without the metabolic syndrome – a 20-year follow-up of a population-based cohort of 60-year-olds	11
Next-generation sequencing to confirm clinical familial hypercholesterolemia	11
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy	11
How to manage an athlete with mitral valve prolapse	11
Validation and comparison of 28 risk prediction models for coronary artery disease	11
Effect of persistent opium consumption after surgery on the long-term outcomes of surgical revascularisation	10
Comparison among different multiparametric scores for risk stratification in heart failure patients with reduced ejection fraction	10
Sex-specific temporal trends in the incidence and prevalence of cardiovascular disease in young adults: a population-based study using UK primary care data	10
Platelet-to-hemoglobin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: A retrospective cohort study	10
Cardiovascular health, genetic predisposition, and lifetime risk of type 2 diabetes	10
The MECKI score initiative: Development and state of the art	10
The effect of high-intensity interval training on exercise capacity in post-myocardial infarction patients: a systematic review and meta-analysis	10
Insulin resistance drives cognitive impairment in hypertensive pre-diabetic frail elders: the CENTENNIAL study	10
Cardiovascular disease burden attributable to non-optimal temperature: analysis of the 1990–2019 global burden of disease	10
Utility of risk prediction models to detect atrial fibrillation in screened participants	10
Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia	10
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set	10
Effects of electrical muscle stimulation on physical function in frail older patients with acute heart failure: a randomized controlled trial	10
Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis	10
Clues and pitfalls in the diagnostic approach to cardiac masses: are pseudo-tumours truly benign?	10
Impact of sex-specific target dose in chronic heart failure patients with reduced ejection fraction	10
Effects of high- and low-load resistance training in patients with coronary artery disease: a randomized controlled clinical trial	10
2019 CORONAVIRUS: What are the implications for cardiology?	10
A window of opportunity on cardiovascular prevention: pre-eclampsia and fetal growth restriction	10
Personalised rehabilitation for cardiac and pulmonary patients with multimorbidity: Time for implementation?	10
Non-invasive estimation of stroke volume during exercise from oxygen in heart failure patients	10
Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study	10